recurrent rectal cancer

Showing 1 - 25 of 50

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Recurrent Rectal Cancer Trial in Saint Louis (Hypofractionated Pencil-Beam Scanning Intensity-modulated Proton Therapy, MEVION

Recruiting
  • Recurrent Rectal Cancer
  • Hypofractionated Pencil-Beam Scanning Intensity-modulated Proton Therapy
  • MEVION S250i Hyperscan and Adaptive Aperture Proton Therapy Machine
  • Saint Louis, Missouri
    Washington University School of Medicine
Dec 8, 2022

Recurrent Rectal Cancer Trial in Shanghai (PD-1 antibody, Capecitabine, Oxaliplatin)

Not yet recruiting
  • Recurrent Rectal Cancer
  • PD-1 antibody
  • +3 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 17, 2022

Recurrent Rectal Cancer, Stage IIA Rectal Cancer, Stage IIB Rectal Cancer Trial in United States (trametinib, fluorouracil,

Active, not recruiting
  • Recurrent Rectal Cancer
  • +6 more
  • Saint Louis, Missouri
  • +3 more
Feb 15, 2022

Rectal Cancer, Colorectal Cancer, Colon Cancer Trial in London (Microstim 2v2 Stimulator)

Active, not recruiting
  • Rectal Cancer
  • +7 more
  • Microstim 2v2 Stimulator
  • London, Greater London, United Kingdom
    London North West University Healthcare NHS Trust
Oct 28, 2021

Comprehensive Gene Sequencing in Guiding Treatment

Completed
  • Recurrent Breast Cancer
  • +7 more
  • cytology specimen collection procedure
  • laboratory biomarker analysis
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
Oct 21, 2021

PelvEx 4: Advanced Pelvic Malignancy and Role of

Not yet recruiting
  • Multidisciplinary Communication
  • +4 more
  • No specific intervention; cases are retrospective and patients have already been treated.
  • Dublin, Ireland
    St. Vincent's Hospital
Oct 12, 2021

Mucinous Adenocarcinoma of the Rectum, Recurrent Rectal Cancer, Signet Ring Adenocarcinoma of the Rectum Trial in Richmond

Completed
  • Mucinous Adenocarcinoma of the Rectum
  • +9 more
  • intensity-modulated radiation therapy
  • +4 more
  • Richmond, Virginia
    Virginia Commonwealth University/Massey Cancer Center
Jul 19, 2021

Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IIA Colon Cancer Trial in Cleveland (positron emission tomography,

Completed
  • Recurrent Colon Cancer
  • +17 more
  • positron emission tomography
  • +3 more
  • Cleveland, Ohio
    University Hospitals Seidman Cancer Center, Case Comprehensive C
Apr 26, 2021

Adult Solid Tumor, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum Trial in Philadelphia (PD-0332991)

Completed
  • Adult Solid Tumor
  • +38 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of The University of Pennsylvania
Feb 18, 2021

3D-PT Assisted CT-guided I-125 Seeds Implantation for Recurrent

Recruiting
  • Recurrent Rectal Cancer
  • +2 more
  • CTV
  • Beijing, Beijing, China
    Peking Unnversity Third Hospital
Jan 13, 2021

Recurrent Rectal Cancer Trial in Toronto (device, radiation, drug)

Unknown status
  • Recurrent Rectal Cancer
  • Magnetic resonance-guided focused ultrasound
  • +2 more
  • Toronto, Ontario, Canada
    Sunnybrook Health Sciences Centre
Dec 15, 2020

Rectal Cancer, Recurrent Rectal Cancer Trial in Netherlands (SGM-101)

Recruiting
  • Rectal Cancer
  • Recurrent Rectal Cancer
  • Amsterdam, Netherlands
  • +3 more
Nov 23, 2020

Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Recurrent Colon Cancer Trial in Houston (saracatinib, laboratory

Terminated
  • Adenocarcinoma of the Colon
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 29, 2019

Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum, Recurrent Colon Cancer Trial in Columbus, Nashville

Unknown status
  • Mucinous Adenocarcinoma of the Colon
  • +7 more
  • panitumumab
  • +3 more
  • Columbus, Ohio
  • +1 more
Mar 25, 2019

Liver Metastases, Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum Trial in Philadelphia

Terminated
  • Liver Metastases
  • +10 more
  • irinotecan-eluting beads
  • hepatic artery embolization
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Feb 22, 2018

Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer Trial in Duarte (MEK inhibitor MEK162, leucovorin

Completed
  • Recurrent Colon Cancer
  • +5 more
  • MEK inhibitor MEK162
  • +5 more
  • Duarte, California
    City of Hope Medical Center
Jan 23, 2018

Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IV Colon Cancer Trial in United States (sorafenib tosylate, bevacizumab)

Completed
  • Recurrent Colon Cancer
  • +3 more
  • sorafenib tosylate
  • bevacizumab
  • Scottsdale, Arizona
  • +210 more
Aug 7, 2017

Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Recurrent Colon Cancer Trial in Rochester, New York, Columbus (FOLFOX

Withdrawn
  • Adenocarcinoma of the Colon
  • +7 more
  • FOLFOX regimen
  • +5 more
  • Rochester, Minnesota
  • +2 more
Apr 3, 2017

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

Terminated
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +33 more
  • Ipilimumab
  • Radiation therapy
  • Stanford, California
    Stanford University
Jan 12, 2017

Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IV A Bladder Cancer Trial in Columbus (PET Scan, CT Scan, fludeoxyglucose

Completed
  • Recurrent Colon Cancer
  • +5 more
  • PET Scan
  • +3 more
  • Columbus, Ohio
    Ohio State University Medical Center
Feb 3, 2016

Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Advanced Adult Primary Liver Cancer Trial in Nashville (cetuximab,

Completed
  • Adenocarcinoma of the Colon
  • +66 more
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Sep 28, 2015

Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IV Colon Cancer Trial in Los Angeles (drug, procedure, genetic, other)

Terminated
  • Recurrent Colon Cancer
  • +3 more
  • Los Angeles, California
    USC/Norris Comprehensive Cancer Center
May 26, 2015

Recurrent Colon Cancer, Extensive Stage Small Cell Lung Cancer, Stage III Pancreatic Cancer Trial run by the NCI (Detox-B

Completed
  • Recurrent Colon Cancer
  • +13 more
  • Detox-B adjuvant
  • ras peptide cancer vaccine
  • Bethesda, Maryland
    Medicine Branch
Apr 27, 2015

Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Recurrent Colon Cancer Trial in Toronto (erlotinib HCl,

Completed
  • Adenocarcinoma of the Colon
  • +5 more
  • erlotinib hydrochloride
  • +2 more
  • Toronto, Ontario, Canada
    Princess Margaret Hospital Phase 2 Consortium
Apr 14, 2015

Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Recurrent Colon Cancer Trial in Boston (biological, drug, other)

Completed
  • Adenocarcinoma of the Colon
  • +7 more
  • pertuzumab
  • +8 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Mar 11, 2015